Literature DB >> 16380275

Ferroportin is a monomer in vivo in mice.

Elisa Pignatti1, Laura Mascheroni, Manuela Sabelli, Samuele Barelli, Stefano Biffo, Antonello Pietrangelo.   

Abstract

Ferroportin (FPN) is the main iron export protein in mammals. The actual structure of FPN in vivo and the pathogenesis of ferroportin-related disease are unknown. We aimed at studying the structure and biochemical properties of FPN in mouse tissues that are key for iron homeostasis during various iron manipulations in vivo. We performed glycosylation and oligomerization studies in spleen and liver extracts from mice fed a standard, iron-deprived or iron-enriched diet for 5 months. Purification by affinity chromatography and sucrose gradient show that FPN is not part of a large multiprotein complex. Dietary manipulations did not affect the monomeric status of the native or denatured protein. The glycosylation studies showed that ferroportin is digested by peptide: N-glycosidase F but not by endoglycosidase H. The same results were obtained using protein extracts from iron-deficient or iron-loaded mice. In conclusion, our studies indicate that mouse FPN, regardless of the tissue iron status, is glycosylated but not enriched in mannose residues, and that exists mainly in monomeric form. The latter finding may have important implications for understanding the pathogenesis of the disease due to ferroportin mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380275     DOI: 10.1016/j.bcmd.2005.11.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  14 in total

1.  Evidence for the multimeric structure of ferroportin.

Authors:  Ivana De Domenico; Diane McVey Ward; Giovanni Musci; Jerry Kaplan
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

Review 2.  Ceruloplasmin-ferroportin system of iron traffic in vertebrates.

Authors:  Giovanni Musci; Fabio Polticelli; Maria Carmela Bonaccorsi di Patti
Journal:  World J Biol Chem       Date:  2014-05-26

Review 3.  Hepcidin and ferroportin: the new players in iron metabolism.

Authors:  Ivana De Domenico; Diane McVey Ward; Jerry Kaplan
Journal:  Semin Liver Dis       Date:  2011-09-07       Impact factor: 6.115

4.  Wild-type and mutant ferroportins do not form oligomers in transfected cells.

Authors:  Ana Sofia Gonçalves; Françoise Muzeau; Rand Blaybel; Gilles Hetet; Fathi Driss; Constance Delaby; François Canonne-Hergaux; Carole Beaumont
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

5.  Ferroportin and erythroid cells: an update.

Authors:  Luciano Cianetti; Marco Gabbianelli; Nadia Maria Sposi
Journal:  Adv Hematol       Date:  2010-08-11

6.  The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.

Authors:  Irene E Zohn; Ivana De Domenico; Andrew Pollock; Diane McVey Ward; Jessica F Goodman; Xiayun Liang; Amaru J Sanchez; Lee Niswander; Jerry Kaplan
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

Review 7.  Liver iron transport.

Authors:  Ross-M Graham; Anita-C-G Chua; Carly-E Herbison; John-K Olynyk; Debbie Trinder
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

8.  Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter.

Authors:  Adrian E Rice; Michael J Mendez; Craig A Hokanson; Douglas C Rees; Pamela J Björkman
Journal:  J Mol Biol       Date:  2009-01-03       Impact factor: 5.469

Review 9.  Ironing out Ferroportin.

Authors:  Hal Drakesmith; Elizabeta Nemeth; Tomas Ganz
Journal:  Cell Metab       Date:  2015-10-01       Impact factor: 27.287

10.  Ferroportin 1 is expressed basolaterally in rat kidney proximal tubule cells and iron excess increases its membrane trafficking.

Authors:  Natascha A Wolff; Wei Liu; Robert A Fenton; Wing-Kee Lee; Frank Thévenod; Craig P Smith
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.